About
Enzymogen has developed a technology platform to manufacture medical-grade cannabinoids. The company uses enzymatic processes to convert natural resources into commercially viable products and improve the efficiency of existing products while maximizing the possibility of commercially viable byproducts. Enzymogen's core functions include full-package projects from clone to final enzyme; clone development in mammals, bacteria, yeast, and algae; process development and optimization; fermenter/bioreactor scale-up; establishment of analytical methods for in-process and release testing; and GMP manufacturing. The company's current product offering includes Taq DNA polymerase (nonbacterial source), human gastric lipase, phospholipase C and D, and cholesterol esterase YEH1 and TGL1.
Q&A
- What is Enzymogen's primary focus?
- Enzymogen focuses on developing a technology platform for manufacturing medical-grade cannabinoids using enzymatic processes to convert natural resources into commercially viable products.
- When was Enzymogen founded?
- Enzymogen was founded in April 2015.
- What is the current status of Enzymogen?
- Enzymogen is currently inactive, having ceased operations in September 2022.
- Who are the co-founders of Enzymogen?
- The co-founders of Enzymogen are Avi Wener and Meir Azulay.
- What are some of Enzymogen's current product offerings?
- Enzymogen's current product offerings include Taq DNA polymerase (nonbacterial source), human gastric lipase, phospholipase C and D, and cholesterol esterase YEH1 and TGL1.
- What sector does Enzymogen operate in?
- Enzymogen operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis.
Team · 2
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | enzymogen-bio.com/ |
|---|---|
| linkedin.com/company/10494325 | |
| facebook.com/enzymogen |
Identifiers & details
| Founded | 2015-4 |
|---|---|
| Employees (exact) | 3 |
| Status reason | Non Active, Sep 2022 ceased to operate |